Protein Biopharmaceuticals @ Bayer: From Discovery to Development
iBET - ITQB SYMPOSIUM
| When |
03 Jul, 2014
from
03:00 pm to 06:50 pm |
|---|---|
| Where | ITQB Auditorium |
| Add event to your calendar |
iCal
|
iBET – ITQB Symposium
Protein Biopharmaceuticals @ Bayer: From Discovery to Development
15h00-15h45 “Expanding role of iBET to support discovery of Human Therapeutic Antibodies at Bayer”
Dr Rene Hoet, Vice President of Global Biologics
15h45-16h30 “Current Development in Antibody Drug Conjugates”,
Dr Heiner Apeler, Director of Purification & Research Analytics
Break 30 min.
17h00-17h45 “Engineering of antibodies for successful development”,
Dr Lars Linden, Head of Protein Biochemistry
17h45-18h30 “Bringing Cell Line Development off the critical path of BMOL drug development”
Dr Beate Müller-Tiemann, Head of Cell and Protein Sciences of Global Biologics
Speakers Affiliation:
BAYER HEALTHCARE AG, WUPPERTAL/KÖLN – GERMANY
Host: Prof Paula Marques Alves, iBET/ITQB-UNL
